The Pharmaceutical JournalCombined oral immunotherapy shows lasting effect against peanut allergy four years laterThe Pharmaceutical JournalIn a study in the Lancet Child & Adolescent Health (online, 15 August 2017), researchers followed up 56 peop… Continue reading
Technology Networks |
Double Helix Technologies teams-up with Agilent Technologies
Technology Networks Double Helix Technologies (Doulix) has announced a collaboration with Agilent Technologies Inc. to promote Agilent’s SureVector next-generation cloning kits through Doulix’s web platform. Through this partnership, synthetic biologists will be able to … Collaboration announced to promote cloning kitsEPM Magazine |
The Durango Herald |
Seeing hope: FDA panel considers gene therapy for blindness
The Durango Herald In this Oct. 4, 2017 photo, Dr. Albert Maguire checks the eyes of Misa Kaabali, 8, at the Children’s Hospital of Philadelphia. Misa was 4 years old when he received his gene therapy treatment. On Thursday, Oct. 12, U.S. Food and Drug Administration … |
Fast Company |
Modifying Your Own Genes Is Just An Injection Away–If You’re Feeling Lucky
Fast Company “What we’ve got here is some DNA, and this is a syringe,” Josiah Zayner tells a room full of synthetic biologists and other researchers. He fills the needle and plunges it into his skin. “This will modify my muscle genes and give me bigger muscles … |
The Philadelphia Tribune |
Gene therapy helps boys with ‘Lorenzo’s Oil’ disease
The Philadelphia Tribune BOSTON — The fledgling field of gene therapy has scored another win: An experimental treatment seemed to help boys with the inherited nerve disease featured in the movie “Lorenzo’s Oil.” Fifteen of the 17 boys treated in a study had no major … |
The Philadelphia Tribune |
Gene therapy helps boys with ‘Lorenzo’s Oil’ disease
The Philadelphia Tribune BOSTON — The fledgling field of gene therapy has scored another win: An experimental treatment seemed to help boys with the inherited nerve disease featured in the movie “Lorenzo’s Oil.” Fifteen of the 17 boys treated in a study had no major … |